- Home
- OGEN vs PRSO Comparison
OGEN vs PRSO Comparison
Compare OGEN & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGEN
- PRSO
- Stock Information
- Founded
- OGEN 1996
- PRSO 2008
- Country
- OGEN United States
- PRSO United States
- Employees
- OGEN N/A
- PRSO N/A
- Industry
- OGEN Biotechnology: Pharmaceutical Preparations
- PRSO Semiconductors
- Sector
- OGEN Health Care
- PRSO Technology
- Exchange
- OGEN Nasdaq
- PRSO Nasdaq
- Market Cap
- OGEN 5.5M
- PRSO 4.0M
- IPO Year
- OGEN N/A
- PRSO 2001
- Fundamental
- Price
- OGEN $0.28
- PRSO $0.89
- Analyst Decision
- OGEN
- PRSO Strong Buy
- Analyst Count
- OGEN 0
- PRSO 2
- Target Price
- OGEN N/A
- PRSO $3.38
- AVG Volume (30 Days)
- OGEN 507.3K
- PRSO 191.2K
- Earning Date
- OGEN 03-28-2025
- PRSO 03-17-2025
- Dividend Yield
- OGEN N/A
- PRSO N/A
- EPS Growth
- OGEN N/A
- PRSO N/A
- EPS
- OGEN N/A
- PRSO N/A
- Revenue
- OGEN N/A
- PRSO $12,728,000.00
- Revenue This Year
- OGEN N/A
- PRSO $9.59
- Revenue Next Year
- OGEN N/A
- PRSO $1.63
- P/E Ratio
- OGEN N/A
- PRSO N/A
- Revenue Growth
- OGEN N/A
- PRSO N/A
- 52 Week Low
- OGEN $0.25
- PRSO $0.73
- 52 Week High
- OGEN $4.00
- PRSO $2.34
- Technical
- Relative Strength Index (RSI)
- OGEN 41.56
- PRSO 41.46
- Support Level
- OGEN $0.34
- PRSO $0.82
- Resistance Level
- OGEN $0.32
- PRSO $0.92
- Average True Range (ATR)
- OGEN 0.03
- PRSO 0.10
- MACD
- OGEN 0.00
- PRSO -0.02
- Stochastic Oscillator
- OGEN 41.80
- PRSO 10.81
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.